Get the Stockscreener App
11.60
2.11%
-0.25
After Hours:
11.60
Y-Mabs Therapeutics Inc Stock (YMAB) Forecast
The Y-Mabs Therapeutics Inc (YMAB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.10, representing a +30.21% increase from the current price of $11.60. The highest analyst price target is $17.15, and the lowest is $13.06.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month YMAB Price Target
Average 19.39
(+67.15% Upside)
Is Y-Mabs Therapeutics Inc (YMAB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 30.78 | Neutral |
| STOCH(9,6) | 5.8203 | Buy |
| STOCHRSI(14) | 1.9225 | Buy |
| MACD(12,26) | -0.9179 | Sell |
| ADX(14) | 26.42 | Sell |
| William %R | -98.41 | Buy |
| CCI(14) | -83.95 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
13.29
Sell
|
12.94
Sell
|
| MA20 |
14.49
Sell
|
13.84
Sell
|
| MA50 |
14.96
Sell
|
14.33
Sell
|
| MA100 |
13.62
Sell
|
13.21
Sell
|
| MA200 |
9.5993
Buy
|
11.04
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, YMAB could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 10 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on YMAB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 30.78 indicates that YMAB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 5.8203 indicates that YMAB is oversold. This indicates that YMAB price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 1.9225 indicates that YMAB is oversold. This suggests that YMAB price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.42 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -83.95 indicates that YMAB is still oversold but not to an extreme extent.
Long-term YMAB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Y-Mabs Therapeutics Inc financial reports and earnings history, Y-Mabs Therapeutics Inc (YMAB) stock could reach $11.08 by 2030, $8.0004 by 2040 and $16.06 by 2050. See the projected annual prices until 2050 of the Y-Mabs Therapeutics Inc stock below:
- Y-Mabs Therapeutics Inc (YMAB) is expected to reach an average price of $3.6518 in 2035, with a high prediction of $3.5953 and a low estimate of $3.8844. This indicates an $-68.52% rise from the last recorded price of $11.60.
- Y-Mabs Therapeutics Inc (YMAB) stock is projected to chart a bullish course in 2040, with an average price target of $8.2015, representing an $-29.30% surge from its current level. The forecast ranges from a conservative $8.5778 to a sky-high $8.0004.
- Our analysts predict Y-Mabs Therapeutics Inc (YMAB) to jump -49.58% by 2045, soaring from $5.9538 to an average price of $5.8486, potentially reaching $4.7786. While $5.9538 is the low estimate, the potential upside is significant.
- Y-Mabs Therapeutics Inc (YMAB) stock is expected to climb by 2050, reaching an average of $13.34, a $15.03% jump from its current level. However, a wide range of estimates exists, with high and low targets of $16.06 and $16.94, respectively, highlighting the market's uncertainty.
Y-Mabs Therapeutics Inc Stock (YMAB) Year by Year Forecast
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2024
Our forecast for YMAB stock price in 2024 now indicates an average price target of $17.58 with a high forecast of $28.68 and a low forecast of $6.48. The average prediction reflects an increase of +51.57% from the last recorded price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $16.59 | $13.06 | $17.15 | +43.00% |
| July, 2024 | $16.64 | $15.39 | $17.82 | +43.41% |
| August, 2024 | $19.60 | $14.98 | $22.58 | +68.94% |
| September, 2024 | $25.23 | $19.19 | $26.24 | +117.49% |
| October, 2024 | $21.11 | $17.55 | $25.40 | +81.95% |
| November, 2024 | $22.68 | $21.10 | $27.06 | +95.50% |
| December, 2024 | $26.86 | $19.31 | $28.68 | +131.54% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2025
Y-Mabs Therapeutics Inc Stock (YMAB) is expected to reach an average price of $26.64 in 2025, with a high prediction of $44.85 and a low estimate of $8.436. This indicates an +129.69% rise from the last recorded price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $24.99 | $24.05 | $28.27 | +115.40% |
| February, 2025 | $27.26 | $23.64 | $30.34 | +134.98% |
| March, 2025 | $22.38 | $21.26 | $29.16 | +92.93% |
| April, 2025 | $18.06 | $8.436 | $24.67 | +55.66% |
| May, 2025 | $28.56 | $17.30 | $28.78 | +146.19% |
| June, 2025 | $32.93 | $25.93 | $34.43 | +183.88% |
| July, 2025 | $42.44 | $30.29 | $42.65 | +265.84% |
| August, 2025 | $34.30 | $33.67 | $44.85 | +195.68% |
| September, 2025 | $32.43 | $28.11 | $36.70 | +179.58% |
| October, 2025 | $32.89 | $30.44 | $38.08 | +183.52% |
| November, 2025 | $32.84 | $30.55 | $37.58 | +183.10% |
| December, 2025 | $37.22 | $31.71 | $38.33 | +220.84% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2026
The predicted value for Y-Mabs Therapeutics Inc (YMAB) in 2026 is set at an average of $34.55. Estimates vary from a peak of $49.70 to a trough of $19.39, indicating an +197.83% surge from the present price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $42.69 | $34.39 | $49.70 | +268.01% |
| February, 2026 | $48.28 | $42.37 | $49.52 | +316.21% |
| March, 2026 | $42.09 | $41.87 | $49.39 | +262.86% |
| April, 2026 | $36.32 | $34.55 | $45.27 | +213.10% |
| May, 2026 | $29.59 | $24.36 | $37.32 | +155.09% |
| June, 2026 | $20.99 | $20.75 | $31.17 | +80.97% |
| July, 2026 | $28.83 | $19.39 | $29.89 | +148.53% |
| August, 2026 | $30.95 | $27.46 | $33.05 | +166.82% |
| September, 2026 | $27.63 | $25.69 | $32.41 | +138.18% |
| October, 2026 | $23.93 | $23.53 | $34.53 | +106.30% |
| November, 2026 | $25.51 | $21.85 | $26.03 | +119.93% |
| December, 2026 | $23.30 | $22.50 | $29.35 | +100.86% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Y-Mabs Therapeutics Inc (YMAB) is $12.83, with a high forecast of $24.29 and a low forecast of $1.3786. This indicates an +10.64% increase from the last price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.33 | $20.41 | $24.29 | +83.89% |
| February, 2027 | $12.95 | $12.71 | $23.29 | +11.66% |
| March, 2027 | $10.98 | $9.7798 | $13.30 | -5.35% |
| April, 2027 | $6.9715 | $6.3315 | $12.89 | -39.90% |
| May, 2027 | $2.5732 | $2.2932 | $6.9066 | -77.82% |
| June, 2027 | $2.9803 | $1.3786 | $4.4603 | -74.31% |
| July, 2027 | $6.8021 | $2.9158 | $8.2966 | -41.36% |
| August, 2027 | $5.8838 | $5.8338 | $9.2129 | -49.28% |
| September, 2027 | $6.6309 | $2.2801 | $6.6399 | -42.84% |
| October, 2027 | $6.4926 | $5.3926 | $9.0822 | -44.03% |
| November, 2027 | $14.33 | $6.9381 | $14.81 | +23.57% |
| December, 2027 | $13.34 | $10.16 | $15.52 | +15.01% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2028
In 2028, Y-Mabs Therapeutics Inc (YMAB) is projected to reach an average price of $7.0682, with a high projection of $13.96 and a low estimate of $0.1804. This indicates an -39.07% fall from the last price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.97 | $9.6178 | $13.96 | -5.40% |
| February, 2028 | $9.5049 | $8.2049 | $11.99 | -18.06% |
| March, 2028 | $1.2779 | $1.3479 | $11.00 | -88.98% |
| April, 2028 | $0.6762 | $1.0017 | $1.1525 | -94.17% |
| May, 2028 | $0.2491 | $0.3991 | $0.5055 | -97.85% |
| June, 2028 | $0.3474 | $0.3728 | $0.3318 | -97.01% |
| July, 2028 | $0.6356 | $0.3511 | $0.1965 | -94.52% |
| August, 2028 | $1.5485 | $0.8902 | $0.8294 | -86.65% |
| September, 2028 | $0.9832 | $0.1804 | $1.5576 | -91.52% |
| October, 2028 | $2.1849 | $0.7595 | $2.4286 | -81.16% |
| November, 2028 | $3.4721 | $1.8104 | $6.2358 | -70.07% |
| December, 2028 | $2.1138 | $1.8338 | $4.2029 | -81.78% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2029
The 2029 price forecast for Y-Mabs Therapeutics Inc Stock (YMAB) is $8.2396 on average, with a high prediction of $16.45 and a low estimate of $0.0328. This represents an -28.97% decrease from the previous price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1.4409 | $1.2009 | $2.8101 | -87.58% |
| February, 2029 | $0.9326 | $0.0328 | $1.8826 | -91.96% |
| March, 2029 | $0.3844 | $0.1289 | $1.0261 | -96.69% |
| April, 2029 | $0.7161 | $0.3398 | $1.2651 | -93.83% |
| May, 2029 | $0.4932 | $0.1526 | $1.2232 | -95.75% |
| June, 2029 | $1.6249 | $0.1387 | $2.2495 | -85.99% |
| July, 2029 | $2.3067 | $1.5204 | $3.1067 | -80.12% |
| August, 2029 | $8.3038 | $1.9721 | $8.8988 | -28.42% |
| September, 2029 | $12.05 | $7.2248 | $12.81 | +3.84% |
| October, 2029 | $11.79 | $9.2227 | $16.45 | +1.66% |
| November, 2029 | $10.71 | $8.9189 | $13.06 | -7.63% |
| December, 2029 | $10.50 | $9.8698 | $12.60 | -9.48% |
Y-Mabs Therapeutics Inc Stock (YMAB) Price Forecast for 2030
Y-Mabs Therapeutics Inc Stock (YMAB) is expected to reach an average price of $13.65 in 2030, with a high forecast of $24.58 and a low forecast of $2.712. This signifies an +17.64% surge from the last price of $11.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $10.36 | $7.0934 | $11.08 | -10.65% |
| February, 2030 | $11.03 | $8.3751 | $11.20 | -4.93% |
| March, 2030 | $11.29 | $10.26 | $11.89 | -2.66% |
| April, 2030 | $14.55 | $9.062 | $16.97 | +25.43% |
| May, 2030 | $14.49 | $13.47 | $20.36 | +24.90% |
| June, 2030 | $19.07 | $11.69 | $19.48 | +64.42% |
| July, 2030 | $17.05 | $13.49 | $21.21 | +46.95% |
| August, 2030 | $20.31 | $17.11 | $22.87 | +75.09% |
| September, 2030 | $20.21 | $18.27 | $22.21 | +74.25% |
| October, 2030 | $21.49 | $17.86 | $24.58 | +85.24% |
| November, 2030 | $6.8112 | $6.1813 | $23.42 | -41.28% |
| December, 2030 | $12.01 | $2.712 | $14.39 | +3.57% |
0.77%
1.20%
Cap:
|
Volume (24h):